Changeflow GovPing Pharma & Drug Safety Genome-wide insulator screening system disclosed
Routine Notice Added Final

Genome-wide insulator screening system disclosed

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO has published a patent application detailing a genome-wide insulator screening system. The system, comprising specific MAI-seq vectors, is designed for high-sensitivity screening of genomic insulators and is applicable to any species.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application (US20260085307A1) filed by inventors Lei HUANG, Yuwen LIU, and Xiusheng ZHU. It discloses a genome-wide insulator screening system that utilizes MAI-seq-experiment and MAI-seq-control vectors. The system's design, with specific arrangements of weak promoters, marker target genes, insertion sites, enhancers, and poly A sites, aims for high sensitivity and accuracy in screening genomic insulators across any species, while mitigating the influence of silencers.

While this is a patent application and not a regulatory rule, it represents a novel disclosure in the field of biotechnology and genetics. Companies involved in drug discovery, genetic research, or the development of diagnostic tools may find this technology relevant. Compliance officers should note that patent disclosures can inform future regulatory considerations or intellectual property strategies within their organizations. There are no immediate compliance obligations or deadlines associated with this patent application publication.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

GENOME-WIDE INSULATOR SCREENING SYSTEM AND USE

Application US20260085307A1 Kind: A1 Mar 26, 2026

Inventors

Lei HUANG, Yuwen LIU, Xiusheng ZHU

Abstract

The present disclosure discloses a genome-wide insulator screening system. The system comprises an MAI-seq-experiment vector and an MAI-seq-control vector; core gene elements in the MAI-seq-experiment vector are arranged in following order: a weak promoter, a marker target gene, an insertion site for a sequence to be screened, an enhancer and a poly A site; and core gene elements in the MAI-seq-control vector are arranged in following order: a weak promoter, a marker target gene, an enhancer, an insertion site for the sequence to be screened and a poly A site. This genome-wide insulator screening system, primarily composed of these two vectors, exhibits high sensitivity and can be applied to the screening of genomic insulators in any species. Furthermore, it effectively eliminates the influence of silencers, ensuring high screening accuracy. This system provides important technical support for constructing insulator maps and understanding the characteristics and mechanisms of action of insulators.

CPC Classifications

C12N 15/1082 C12N 15/66 C12Q 1/6806 C12Q 1/6809 C12Q 1/6855 C12Q 1/686 C12Q 1/6869 C12N 2830/50

Filing Date

2025-01-15

Application No.

19021326

View original document →

Named provisions

Abstract Inventors CPC Classifications

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260085307A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Genetic Research Biotechnology Development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Biotechnology Genetics

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!